📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

BRIEF-Zenitas Healthcare acquires Dimple Group

Published 27/07/2017, 09:46 am
© Reuters.  BRIEF-Zenitas Healthcare acquires Dimple Group
ZNT
-

July 27 (Reuters) - Zenitas Healthcare Ltd ZNT.AX

* Announces that it has acquired 100% of dimple group

* Zenitas reaffirms prospectus pro forma forecast ebitda of $6.6m for Fy17. Post transaction, pro forma FY17 ebitda would increase to $11.8m

* Transaction funded via $10.7 mln of cash and bank debt and $2.7 mln of zenitas scrip

* Deal highly accretive to zenitas eps, with pro forma fy17 eps accretion of 22% after non- controlling interests and pre-synergy benefit

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.